Publisher
Springer Science and Business Media LLC
Reference7 articles.
1. Nederlands Huisartsen Genootschap. Multidisciplinaire richtlijn Cardiovasculair risicomanagement. Utrecht: NHG , 2011.
2. Menotti A, Kromhout D, Blackburn H, Jacobs D, Lanti M. Fortyyear mortality from cardiovascular diseases and all causes of death in the US Railroad cohort of the Seven Countries Study. Eur J Epidemiol 2004;19: 417-24.
3. Shepherd J, Blauw GJ, Murphy MB, Bollen EL, Buckley BM, Cobbe SM, et al. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): A randomised controlled trial. Lancet 2002;360:1623-30.
4. CVZ. Farmacotherapeutisch Kompas. Diemen: CVZ; 2013. www.fk.cvz.nl .
5. Baigent C, Keech A, Kearney PM, Blackwell L, Buck G, Pollicino C, et al. Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 2005;366:1267-78.